logo
  • Home
  • News
Menu

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

Home / Stock Analysis / GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A
Article feature image

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

12 Aug Stock Analysis

YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma (006280.KS) today announced the approval of GreenGene F (Beroctocog alfa)

Click here to view the original article.

Tags:
Business Wire, Global
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

hul-share-price-today-live-updates-19-sep-2025.jpg
+

HUL Share Price Highlights: HUL Stock Price History

20 Sep Stock Analysis
tech-mahindra-stock-price-livestock-price-today-live-updates-19-sep-2025.jpg
+

Tech Mahindra Share Price Highlights: Tech Mahindra Stock Price History

20 Sep Stock Analysis

recent post

  • image3-1081.jpg

    ADA Price Prediction; XRP Latest News

    Sep 20 2025
  • Image-7-4-scaled.png

    U.S. CFTC Names 8 New Leaders

    Sep 20 2025
  • 1758353746_1200x800.jpg

    Crypto Custody Firm BitGo Files for

    Sep 20 2025
  • 6f9e3b90e6e26a76e6984fc6b8a42e27.jpeg

    Jim Cramer Appreciates Gemini’s Crypto Pioneering

    Sep 20 2025
  • 1-1007.png

    Will Snorter Bot 10x This Year?

    Sep 20 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.